Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Aquestive Therapeutics, Inc. (AQST) had Non-Operating Income/Expense of $-3.85M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$14.45M |
|
$-8.06M |
|
$3.47M |
|
$10.98M |
|
$18.65M |
|
$-4.20M |
|
|
Non-Operating Income/Expense |
$-3.85M |
$-8.06M |
|
$-8.06M |
|
$-8.06M |
|
$-8.06M |
|
$-8.06M |
|
$-8.06M |
|
$-4.20M |
|
$-1.80M |
|
122.61M |
|
122.61M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$130.18M |
|
$3.84M |
|
$10.94M |
|
$141.12M |
|
$31.75M |
|
$25.10M |
|
$143.43M |
|
$175.18M |
|
$-34.05M |
|
$-34.05M |
|
$-34.05M |
|
124.28M |
|
| Cash Flow Statement Financials | |
$-14.81M |
|
$-0.05M |
|
$4.42M |
|
$121.17M |
|
$110.73M |
|
$-10.44M |
|
$2.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.10 |
|
-- |
|
-- |
|
-2.80 |
|
-0.74 |
|
75.99% |
|
-29.10% |
|
-29.10% |
|
-- |
|
-55.77% |
|
-55.77% |
|
$-14.86M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.43 |
|
2.10 |
|
42.78 |
|
23.66% |
|
23.66% |
|
-5.71% |
|
89.97% |
|
$-0.27 |
|
$-0.12 |
|
$-0.12 |
|